Article Text

other Versions

Electronic cigarettes: analysis of FDA adverse experience reports in non-users
  1. Elizabeth L Durmowicz,
  2. Susan F Rudy,
  3. Ii-Lun Chen
  1. Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, Maryland, USA
  1. Correspondence to Dr Elizabeth L Durmowicz, Office of Science, Center for Tobacco Products, Food and Drug Administration, WO 75/Room 5476, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA; Elizabeth.durmowicz{at}

Statistics from

The US Food and Drug Administration (FDA) Center for Tobacco Products (CTP) receives and reviews voluntary reports from consumers, healthcare professionals and members of the public on adverse experiences (AEs) associated with tobacco products. Reports from consumers and concerned citizens have described AEs not only in users, but also in non-users of e-cigarettes.1 ,2

AE reports received by FDA between 1 January 2012 and 31 December 2014 were reviewed to evaluate AEs associated with e-cigarettes in non-users. The reports were received via the Safety Reporting Portal, MedWatch, mail and email. Of 136 reports related to e-cigarette AEs, 40 involved non-users (table 1).

View this table:
Table 1

Tobacco product adverse experience reports submitted to FDA*

Thirty-five reports were related to passive aerosol exposure (typically in indoor spaces). Respiratory symptoms …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.